Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

2 structures for O75663

Entry ID Method Resolution Chain Position Source
5D9G X-ray 215 A A/B 16-256 PDB
AF-O75663-F1 Predicted AlphaFoldDB

149 variants for O75663

Variant ID(s) Position Change Description Diseaes Association Provenance
rs1265988654
CA343081370
2 M>I No ClinGen
gnomAD
rs1199162254
CA343081342
2 M>K No ClinGen
TOPMed
CA31454976
rs891528712
4 H>N No ClinGen
Ensembl
rs746172242
CA1229876
4 H>Q No ClinGen
ExAC
gnomAD
CA1229877
rs772353524
8 S>C No ClinGen
ExAC
gnomAD
CA1229878
rs775627089
8 S>N No ClinGen
ExAC
gnomAD
CA1229879
rs760815085
8 S>R No ClinGen
ExAC
gnomAD
CA343081691
rs1572426929
10 H>P No ClinGen
Ensembl
CA343081736
rs1572426940
TCGA novel
12 D>G Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
Ensembl
rs1029481863
CA31454991
13 F>I No ClinGen
Ensembl
rs768711827
CA343081860
14 C>F No ClinGen
ExAC
gnomAD
CA343081841
rs1465582648
14 C>G No ClinGen
gnomAD
CA1229880
rs768711827
14 C>S No ClinGen
ExAC
gnomAD
CA343081875
rs1255865387
15 F>L No ClinGen
TOPMed
rs1478313027
CA343081953
17 P>T No ClinGen
gnomAD
rs776601529
CA1229881
19 K>R No ClinGen
ExAC
gnomAD
rs1459479070
CA343082097
20 L>M No ClinGen
gnomAD
rs761839555
CA1229882
21 T>A No ClinGen
ExAC
gnomAD
rs1350124740
CA343082136
21 T>R No ClinGen
TOPMed
gnomAD
rs1379364925
CA343082235
23 S>C No ClinGen
TOPMed
CA343082276
rs1438115101
24 K>N No ClinGen
gnomAD
rs955676480
CA31454995
25 T>S No ClinGen
TOPMed
gnomAD
CA31455008
rs985559103
26 H>L No ClinGen
Ensembl
rs1339646550
CA343082358
27 I>V No ClinGen
gnomAD
rs371476972
CA31455012
31 A>T No ClinGen
Ensembl
rs752266948
CA1229908
38 D>N No ClinGen
ExAC
TOPMed
gnomAD
rs1041169699
CA31457153
39 E>D No ClinGen
TOPMed
rs879181819
CA31457162
41 H>R No ClinGen
Ensembl
CA343085002
rs1160266672
41 H>Y No ClinGen
gnomAD
CA1229910
rs765840211
42 M>K No ClinGen
ExAC
TOPMed
gnomAD
rs765840211
CA343085020
42 M>T No ClinGen
ExAC
TOPMed
gnomAD
CA343085014
rs1211967147
42 M>V No ClinGen
TOPMed
CA1229911
rs750885301
44 S>A No ClinGen
ExAC
gnomAD
CA1229912
rs758814194
44 S>Y No ClinGen
ExAC
gnomAD
rs747323502
CA1229914
47 E>A No ClinGen
ExAC
gnomAD
rs576096534
CA1229916
50 F>L No ClinGen
1000Genomes
ExAC
gnomAD
rs371542831
CA1229915
50 F>S No ClinGen
ESP
ExAC
gnomAD
CA1229920
rs749206057
54 V>I No ClinGen
ExAC
TOPMed
gnomAD
rs770949861
CA1229921
55 L>* No ClinGen
ExAC
gnomAD
CA1229922
rs770949861
55 L>S No ClinGen
ExAC
gnomAD
rs1179051863
CA343085335
56 R>G No ClinGen
gnomAD
rs1236989574
CA343085400
57 I>M No ClinGen
gnomAD
CA1229923
rs759348099
60 G>E No ClinGen
ExAC
TOPMed
gnomAD
CA343085771
rs1335065339
68 N>S No ClinGen
TOPMed
CA1229925
rs375553827
70 T>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
COSM207668
rs760294386
CA1229926
72 A>V Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA343085932
rs1558162349
74 R>K No ClinGen
Ensembl
rs758938659
CA1229929
75 C>R No ClinGen
ExAC
TOPMed
gnomAD
CA343085963
rs1376312985
75 C>Y No ClinGen
gnomAD
CA343086024
rs1459578508
77 N>K No ClinGen
TOPMed
rs1030012310
CA31457228
78 N>Y No ClinGen
TOPMed
CA31457231
rs952993404
79 Y>H No ClinGen
TOPMed
CA343086403
rs1447565734
90 E>K No ClinGen
gnomAD
rs1311817536
CA343086449
92 Q>K No ClinGen
gnomAD
rs766811520
CA1229930
93 E>D No ClinGen
ExAC
gnomAD
rs937328464
CA31457477
96 T>A No ClinGen
TOPMed
gnomAD
CA1229948
rs61744533
96 T>M No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs917498929
CA31457482
98 G>A No ClinGen
TOPMed
gnomAD
CA343086843
rs776016165
98 G>R No ClinGen
ExAC
gnomAD
rs776016165
CA1229949
98 G>S No ClinGen
ExAC
gnomAD
CA343086869
rs1360666347
99 E>D No ClinGen
gnomAD
CA343086877
rs1363307956
100 H>L No ClinGen
TOPMed
CA343086879
rs1363307956
100 H>R No ClinGen
TOPMed
CA1229950
rs761244356
100 H>Y No ClinGen
ExAC
gnomAD
CA343086897
rs1319195489
101 S>C No ClinGen
gnomAD
CA1229951
rs766934400
101 S>P No ClinGen
ExAC
gnomAD
CA343086972
rs752044854
104 V>F No ClinGen
ExAC
gnomAD
rs752044854
CA1229952
104 V>I No ClinGen
ExAC
gnomAD
rs759942366
CA1229953
105 I>M No ClinGen
ExAC
gnomAD
rs1487973524
CA343087045
107 P>A No ClinGen
gnomAD
rs148311054
CA1229957
116 Y>D No ClinGen
ESP
ExAC
gnomAD
TCGA novel 117 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 123 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 124 S>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1007306829
CA31457516
125 L>F No ClinGen
gnomAD
CA1229958
rs753974254
125 L>H No ClinGen
ExAC
TOPMed
gnomAD
rs1211303368
CA343089411
129 V>I No ClinGen
gnomAD
CA31460784
rs372428067
130 V>I No ClinGen
Ensembl
rs780921720
CA1229971
133 T>A No ClinGen
ExAC
TOPMed
gnomAD
rs1377400270
CA343089502
133 T>K No ClinGen
TOPMed
rs761366919
CA1229972
134 D>N No ClinGen
ExAC
TOPMed
gnomAD
CA1229973
rs769267756
135 H>P No ClinGen
ExAC
gnomAD
TCGA novel 135 H>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 137 D>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA343089606
rs1442373030
139 E>Q No ClinGen
TOPMed
gnomAD
CA343089925
rs1166726533
150 F>L No ClinGen
TOPMed
rs1051867321
CA31460814
153 V>I No ClinGen
TOPMed
gnomAD
CA31460835
rs767516821
160 L>R No ClinGen
Ensembl
CA343090205
rs1286257453
164 G>E No ClinGen
gnomAD
TCGA novel 167 S>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1156680360
CA343090275
167 S>R No ClinGen
gnomAD
CA1229979
rs764291936
169 S>R No ClinGen
ExAC
gnomAD
rs1423235090
CA343090432
172 I>M No ClinGen
TOPMed
rs757463299
CA1229981
172 I>T No ClinGen
ExAC
gnomAD
CA343092276
rs1477742589
174 V>E No ClinGen
gnomAD
CA1230003
rs764532151
174 V>I No ClinGen
ExAC
TOPMed
gnomAD
rs530840370
CA31464300
177 S>C No ClinGen
TOPMed
gnomAD
CA31464311
rs367553853
178 S>G No ClinGen
ESP
rs762161696
CA1230006
184 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs777036548
CA1230005
184 R>W No ClinGen
ExAC
gnomAD
rs765509729
CA1230007
185 F>V No ClinGen
ExAC
gnomAD
rs1572436980
CA343092676
192 V>G No ClinGen
Ensembl
rs766282474
CA1230010
192 V>M No ClinGen
ExAC
TOPMed
gnomAD
CA1230012
rs751488353
199 T>K No ClinGen
ExAC
TOPMed
gnomAD
rs751488353
CA343092840
199 T>M No ClinGen
ExAC
TOPMed
gnomAD
CA1230011
rs751488353
199 T>R Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs542882842
CA31464327
200 R>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1289504737
CA343092948
203 H>Y No ClinGen
gnomAD
rs1247053027 205 A>= Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1186262130
CA343093830
205 A>T No ClinGen
gnomAD
CA1230032
rs751552308
208 T>A No ClinGen
ExAC
gnomAD
rs759490884
CA1230033
209 Y>H No ClinGen
ExAC
gnomAD
rs1420138780
CA343093869
210 M>I No ClinGen
gnomAD
CA1230034
rs765306922
210 M>L No ClinGen
ExAC
TOPMed
gnomAD
rs1325075001
CA343093883
212 R>Q No ClinGen
TOPMed
TCGA novel 213 E>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 214 Y>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA1230035
rs752492412
215 T>M No ClinGen
ExAC
TOPMed
gnomAD
CA343093919
rs1333620722
217 R>Q No ClinGen
gnomAD
CA343093971
rs1454620575
219 S>N No ClinGen
TOPMed
gnomAD
CA343093981
rs1307436513
219 S>R No ClinGen
gnomAD
CA1230038
rs753509670
220 K>R Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
TCGA novel 222 S>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA343094129
rs1240230319
225 M>T No ClinGen
gnomAD
CA343094359
rs1471032314
226 H>R No ClinGen
gnomAD
rs1348389554
CA343094391
228 P>L No ClinGen
TOPMed
CA1230051
rs144016855
229 P>R No ClinGen
ESP
ExAC
gnomAD
CA1230053
rs760512618
230 S>F No ClinGen
ExAC
gnomAD
rs1038788182
CA31466200
231 L>H No ClinGen
TOPMed
CA1230054
rs763920417
231 L>V No ClinGen
ExAC
TOPMed
gnomAD
CA343094468
rs1326202616
233 T>M No ClinGen
gnomAD
CA343094509
rs1427059050
235 P>R No ClinGen
TOPMed
CA1230056
rs756959228
238 I>K No ClinGen
ExAC
gnomAD
rs779054395
CA1230057
239 S>F No ClinGen
ExAC
gnomAD
CA1230058
rs749962048
240 Q>R No ClinGen
ExAC
gnomAD
CA1230060
rs781775909
247 A>T No ClinGen
ExAC
TOPMed
gnomAD
rs748631632
CA1230061
249 C>G No ClinGen
ExAC
gnomAD
rs1250770452
CA343095002
253 I>R No ClinGen
TOPMed
rs1558166866
CA343094990
253 I>V No ClinGen
Ensembl
rs746302570
CA31466228
257 R>K No ClinGen
TOPMed
rs368864556
CA1230065
264 D>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA343095222
rs1314276870
266 Q>H No ClinGen
TOPMed
rs771188615
CA1230066
266 Q>K No ClinGen
ExAC
gnomAD
TCGA novel 267 K>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA343095252
rs1386576626
268 S>G No ClinGen
gnomAD
TCGA novel 268 S>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs892544453
CA343095261
268 S>R No ClinGen
gnomAD
rs1302365354
CA343095273
269 T>A No ClinGen
TOPMed
CA343095310
rs1372338072
271 V>M No ClinGen
gnomAD

No associated diseases with O75663

No regional properties for O75663

Type Name Position InterPro Accession
No domain, repeats, and functional sites for O75663

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.

No GO annotations of molecular function

Name Definition
No GO annotations for molecular function

4 GO annotations of biological process

Name Definition
DNA damage checkpoint signaling A signal transduction process that contributes to a DNA damage checkpoint.
negative regulation of phosphoprotein phosphatase activity Any process that stops or reduces the activity of a phosphoprotein phosphatase.
regulation of phosphoprotein phosphatase activity Any process that modulates the frequency, rate or extent of phosphoprotein phosphatase activity, the catalysis of the hydrolysis of phosphate from a phosphoprotein.
TOR signaling The series of molecular signals mediated by TOR (Target of rapamycin) proteins, members of the phosphoinositide (PI) 3-kinase related kinase (PIKK) family that act as serine/threonine kinases in response to nutrient availability or growth factors.

1 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P34274 C02C2.6 TIP41-like protein Caenorhabditis elegans PR
10 20 30 40 50 60
MMIHGFQSSH RDFCFGPWKL TASKTHIMKS ADVEKLADEL HMPSLPEMMF GDNVLRIQHG
70 80 90 100 110 120
SGFGIEFNAT DALRCVNNYQ GMLKVACAEE WQESRTEGEH SKEVIKPYDW TYTTDYKGTL
130 140 150 160 170 180
LGESLKLKVV PTTDHIDTEK LKAREQIKFF EEVLLFEDEL HDHGVSSLSV KIRVMPSSFF
190 200 210 220 230 240
LLLRFFLRID GVLIRMNDTR LYHEADKTYM LREYTSRESK ISSLMHVPPS LFTEPNEISQ
250 260 270
YLPIKEAVCE KLIFPERIDP NPADSQKSTQ VE